PubMed:32736597 / 4047-4328
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T92 | 186-194 | SP_7 | denotes | COVID-19 |
| T93 | 230-248 | CHEBI:5801 | denotes | hydroxychloroquine |
| T94 | 230-248 | DG_20 | denotes | hydroxychloroquine |
| T95 | 230-248 | CHEBI:5801 | denotes | hydroxychloroquine |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T34 | 186-194 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T51 | 139-140 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T31 | 230-248 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 0-281 | Sentence | denotes | During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 132 | 186-194 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 133 | 230-248 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |